ArticleJournal of neuro-oncology2018

Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.

Nathan J Robison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.